Overview of the $600 million disbursement to Gavi

On July 29, 2026, the U.S. State Department and Department of Health and Human Services confirmed the disbursement of $600 million to Gavi, an important international organization that supports poor countries in purchasing and distributing vaccines. The funding was approved by the U.S. Congress for fiscal years 2025 and 2026 and is expected to expire on September 30.

The disbursement marks the end of a prolonged stalemate that had lasted for months, caused by Health and Human Services Secretary Robert F. Kennedy Jr.'s refusal to fund the organization based on his concerns about vaccine safety.

Response from Health and Human Services Secretary Robert F. Kennedy Jr. and views on mercury-containing vaccines

In 2025, Kennedy criticized Gavi for using vaccines he deemed 'hazardous and outdated' due to their mercury-containing thimerosal component. He also expressed a desire to completely eliminate remaining thimerosal-containing vaccines in the U.S., particularly multi-dose vial flu vaccines.

However, leading global vaccine experts have confirmed the safety of the vaccines currently used by Gavi. The U.S. has gradually phased out thimerosal-containing vaccines over more than two decades due to concerns raised in the system 90s and early 2000s, but fully replacing them remains challenging in many countries due to cold chain storage limitations.